This is a strategic initiative because mRNA technology can also be used to develop other virus vaccines 💉 for relevant public health problems in our Region such as Zika, Dengue fever and other 🦠
… – the public producer Bio-Manguinhos Institute of Technology on Immunobiologicals at the Oswaldo Cruz Foundation in Brazil, and the private company Sinergium Biotech in Argentina…
…– to receive technical support from PAHO and WHO to accelerate the development and production of mRNA vaccines 💉, the same technological platform used by Pfizer and Moderna, in Latin America and the Caribbean.
After reviewing 🔍 more than 30 proposals 📄, an external and independent committee of experts selected two projects…
As we address these immediate gaps, PAHO is also working to expand our region’s manufacturing capacity to build a more sustainable and dependable supply of vaccines 💉 and medical technologies.
We have reached an agreement with Sinovac & have begun accepting orders that will be ready for delivery this year, & we are expecting to sign new agreements in the coming days to buy 💉 that have Emergency Use Listing approval from other suppliers for 2021 & 2022
Our Revolving Fund is in advanced discussions with vaccine manufacturers to purchase additional COVID vaccines 💉 on behalf of our Member States, to complement bilateral deals, donations 📦, and doses they are receiving via the COVAX mechanism.
We must use all possible strategies to access more doses 💉
Special attention is also focused on uptake of vaccines 💉 in the areas affected by the earthquake.
For example, we are on the ground in Haiti 🇭🇹 helping the country make the most of the vaccines it has on hand and working with the Haitian governments and international partner NGOs to plan for additional allocations of vaccine supply in the coming months
